ABU DHABI, United Arab Emirates, Oct. 03, 2026 (GLOBE NEWSWIRE) — FREELANDER held its Global Brand Launch at Emirates Palace Mandarin Oriental in Abu Dhabi on 29 September 2026, opening a new chapter in its international development. Eight distinguished guests bearing the title of His Excellency attended, alongside government representatives, business partners and media. Charlie Zhang, Executive Vice President of Chery International, addressed the event, reaffirming Chery Group’s long-term commitment to FREELANDER and its determination to deepen its presence in the Middle East while expanding internationally.FREELANDER 8’s first international unveiling in Abu Dhabi Guests included His Excellency Hamad Sayah Al Mazrouei, Undersecretary of the Abu Dhabi Department of Economic Development; His Excellency Rashed Al Blooshi, CEO of...

WUHU, China, Oct. 03, 2026 (GLOBE NEWSWIRE) — On September 30, LEPAS, Chery Auto’s Premium NEV brand, launched the LEPAS L8 PHEV in Romania and opened its first flagship store in Sibiu, giving customers an experience of elegant mobility.Hedy Yan, LEPAS brand representative, said: “Elegance is both design and a mobility mindset. Through ‘Drive Your Elegance’, we bring design, tech and comfort to daily travel for Romanian users via the LEPAS L8 PHEV.” Elegance at the Core: A New NEV Mobility Experience Aiming to become the “Preferred Brand for Elegant Mobility Life,” LEPAS is built around three core pillars: Leopard Aesthetics, Exquisite Space and Elegant Technology, bringing elegance to daily life. Since Q3 this year, the LEPAS L8 PHEV has been progressing through launch and pre-sale stages across Europe, with Romania a key...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 02, 2026 (GLOBE NEWSWIRE) — Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (OTCQB: PPURF) (“Purecore” or the “Company”) is pleased to announce that it intends to complete a non-brokered private placement for aggregate gross proceeds of up to C$2,500,000 (the “Offering”). The Offering will consist of a combination of hard dollar units of the Company (the “HD Units”) at a price of C$1.35 per HD Unit and flow-through units of the Company (the “FT Units”) at a price of C$1.50 per FT Unit. Hard Dollar Units Each HD Unit will consist of one Common Share and one Warrant. Each Warrant comprising the HD Units will entitle the holder thereof to acquire one Warrant Share at an exercise price of C$2.00 per Warrant...

/ NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES / Toronto, Oct. 02, 2026 (GLOBE NEWSWIRE) — Plato Gold Corp. (TSX-V: PGC) (OTCQB: NIOVF) (Frankfurt: 4Y7 or WKN: A0M2QX) (“Plato” or the “Company”) announces that it has closed an initial tranche of its previously announced non-brokered critical-mineral flow-through private placement (the “Offering”). The Company issued, effective September 29, 2026, 1,100,000 flow-through common shares (the “FT Shares”) at $0.05 per FT Share for gross proceeds of $55,000. No warrants were issued. The Offering was announced on September 9, 2026 for aggregate gross proceeds of up to $150,000 and may be completed in one or more additional closings. Each FT Share is intended to qualify as a “flow-through share” within the meaning of the Income Tax Act...

Key Highlights 1.07 million indicated ounces of gold at 0.96 g/t contained in 34.68 million tonnes1 5.09 million inferred ounces of gold at 0.87 g/t contained in 183.05 million tonnes1 This represents a 61% increase in inferred resources and a 6% increase in indicated resources from previous technical report having an effective date of September 29, 2025 Overall gold recoveries at 92% New drilling permit extends drilling program to August 2029 Two more drills are being added this month Filed Technical Report reflects a minor amendment where inferred resources have increased by 30,000 ounces and indicated resources decreased by 70,000 ounces to the estimate announced August 17, 2026 See note 1 below Table 1TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) — McFarlane Lake Mining Limited (“McFarlane” or the “Company”) (CSE: MLM, OTC: MLMLF),...

TORONTO, Oct. 02, 2026 (GLOBE NEWSWIRE) — Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”) reported on its capital markets activity for the previous quarter, including activity under its at-the-market equity program (“ATM”) and equity participation by employees and directors. The Company’s equity participation programs support alignment between employees, directors and shareholders through market-based equity ownership. Under the Company’s Employee Share Purchase Program (“ESP”), a total of 37,341 common shares (“Common Shares”) were purchased by employees during the third quarter, with a corresponding 37,341 Common Shares acquired by the Company in accordance with the program. Employee participation included meaningful purchases by Company management. Approved by shareholders at the...

São Paulo, Oct. 02, 2026 (GLOBE NEWSWIRE) — Marfrig Global Foods S.A. (“MBRF”) (B3: MBRF3; ADR Level 1: MBRFY), through its subsidiary, NBM US Holdings, Inc. (“NBM” or the “Offeror”), announced today that it has terminated its previously announced offer to purchase for cash from each registered holder (each, a “Holder” and, collectively, the “Holders”) any and all of the outstanding 6.625% Senior Notes due 2029 (CUSIP Nos. 62877V AB7; U63768 AB8 / ISIN Nos. US62877VAB71; USU63768AB83) issued by NBM, with US$467,471,000 in aggregate principal amount outstanding (the “Notes” and the “Offer”, respectively), the terms and conditions of which are described in an Offer to Purchase dated September 28, 2026 (the “Offer to Purchase”), as a result of the Financing Condition (as defined below) not having been satisfied. The Offer was conditioned...

PERTH, Australia, Oct. 02, 2026 (GLOBE NEWSWIRE) — Chilwa Minerals Limited, an Australian company (ASX:CHW, NASDAQ:CHWM) (Chilwa or the Company), is pleased to announce the closing of its underwritten public offering. The offering consisted of 625,000 American Depositary Shares (“ADSs“) and warrants to purchase 625,000 ADSs at an offering price of US$5.60 per ADS and accompanying warrant. Each ADS offered represents 10 ordinary shares of Chilwa. The gross proceeds, before deducting underwriter discounts and offering expenses, were US$3.5 million. The warrants have an exercise price of US$5.60 per ADS, are exercisable immediately upon issuance and expire on the fifth anniversary of the original issuance date. The ADSs began trading on the Nasdaq Capital Market under the ticker symbol “CHWM” on October 1, 2026. In addition,...

HONOLULU, Oct. 02, 2026 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that it plans to release its third quarter 2026 financial results on Friday, October 23, 2026 before the market opens. First Hawaiian will host a conference call to discuss the company’s results on the same day at 1:00 p.m. Eastern Time (7:00 a.m. Hawaii Time). To access the call by phone, participants will need to click on the following registration link: https://register-conf.media-server.com/register/BI4e0abe37ecf34f5d8bdacfb166cade22, register for the conference call, and then you will receive the dial-in number and a personalized PIN code. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A live webcast of the conference call, including a slide presentation,...

The US Food and Drug Administration (FDA) has informed Novo that the BLA review of denecimig for the treatment of haemophilia A is still ongoing. The FDA has not communicated a new timeline for regulatory action on the BLA  The FDA has informed Novo that the ongoing facility remediation activities are the cause for extension of the Agency’s review. The FDA has not identified any deficiencies related to the clinical efficacy or safety data submitted in the denecimig BLA Novo is actively working with the FDA, addressing the Agency’s requests for remediations related to the manufacturing facility. The extended FDA review time for the denecimig BLA has no impact on Novo’s financial outlook for 2026 and pending regulatory decision, Novo aims to launch denecimig in the US in the first half of 2027Bagsværd, Denmark, 02 October...